09-09-2017 Our new distributors; IWAI JAPAN and USA, BioChemMack JCS Russia
07-27-2017 5 New publications are added; 2 patents, 2 peer reviewed articles and 1 PhD thesis.
07-10-2017 five new products for Pembrolizumab(Keytruda®),Ipilimumab(Yervoy®) and Filgrastim,
02-20-2017 new publication “H. Akbulut, et al: The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC). 1553 P, Annals of Oncology, Volume 27, 2016,
02-20-2017 New kit for quantitative measurement of anti-bevacizumab antibodies with confirmation reagent
02-06-2017 Two new kits for quantitative measurement of rituximab and anti-rituximab antibodies with confirmation reagent
01-30-2017 Three new kits for quantitative measurement of anti-drug antibodies for infliximab, infliximab biosimilar CT-P13 and adalimumab with confirmation reagent
01-13-2017 Updated forty publications done by using SHIKARI® ELISA kits